Cargando…

2578. Narrow-Spectrum Antibiotic Treatment of Clostridium difficile Infection Improves Preservation of Intestinal Metabolic Profile

BACKGROUND: Commensal gut bacteria are thought to protect against C. difficile infection (CDI) by producing metabolites that inhibit C. difficile germination and growth. Alternatively, the protective effect could reflect nutrient competition or other mechanisms of chemical communication that also in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Seoyoung, Yanagi, Karin, Kane, Anne, Snydman, David R, Vickers, Richard, Thorpe, Cheleste M, Lee, Kyongbum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810114/ http://dx.doi.org/10.1093/ofid/ofz360.2256

Ejemplares similares

Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids
por: Qian, Xi, et al.
Publicado: (2020)

2567. Effect of Broad vs. Narrow-Spectrum Clostridioides difficile Treatment on Human Stool Bile Acid Composition Over Time
por: Thorpe, Cheleste M, et al.
Publicado: (2019)

Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin
por: Thorpe, Cheleste M., et al.
Publicado: (2018)

1774. Ridinilazole (RDZ) for Clostridium difficile infection (CDI): Correlation of In Vitro Spectrum of Activity with Human Gut Microbiome Profiles from a Phase 2 Clinical Trial
por: Vickers, Richard, et al.
Publicado: (2018)

Epidemiologic Trends in Clostridium difficile Isolate Ribotypes in United States from 2010 to 2014
por: Snydman, David R, et al.
Publicado: (2017)

Ridinilazole: a novel, narrow‐spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile
por: Collins, Deirdre A, et al.
Publicado: (2022)

Clostridium difficile and Antibiotic-associated Diarrhea
por: Bhattacharyya, Mahuya, et al.
Publicado: (2020)

Antibiotics Associated With Clostridium difficile Infection
por: Rafey, Abdur, et al.
Publicado: (2023)

833 Lactobacillus GG (LGG) Does Not Eliminate Colonization by Vancomycin Resistant Enterococcus (VRE) in Adults with Comorbidities
por: Doron, Shira, et al.
Publicado: (2014)

2578. Trends in Pathogens and Antibiotic Treatment in Children with Cystic Fibrosis in 2018 and 2022: A Retrospective Multicenter Study
por: Stout, Dayna, et al.
Publicado: (2023)

Clostridium difficile colonization and antibiotics response in PolyFermS continuous model mimicking elderly intestinal fermentation
por: Fehlbaum, Sophie, et al.
Publicado: (2016)

Presence and molecular characterization of Clostridium difficile and Clostridium perfringens in intestinal compartments of healthy horses
por: Schoster, Angelika, et al.
Publicado: (2012)

Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection
por: Chilton, C. H., et al.
Publicado: (2016)

Effect of Bifidobacterium breve in Combination With Different Antibiotics on Clostridium difficile
por: Yang, Jingpeng, et al.
Publicado: (2018)

Incidence of Clostridium difficile Infection After Sepsis Protocol Antibiotics
por: LaFave, Jordan, et al.
Publicado: (2019)

Community acquired Clostridium difficile in an infant without antibiotic exposure
por: Singh, Jaspreet, et al.
Publicado: (2020)

Early diagnosis and antibiotic treatment for fulminant Clostridium difficile infection
por: Fukushima, Kazutaka, et al.
Publicado: (2020)

In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile
por: Corbett, D., et al.
Publicado: (2015)

The discovery of a novel antibiotic for the treatment of Clostridium difficile infections: a story of an effective academic–industrial partnership
por: Mann, John, et al.
Publicado: (2015)

Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection()
por: Adamu, Blessing O, et al.
Publicado: (2013)

Epidemiological Features of Clostridium difficile Colonizing the Intestine of Jordanian Infants
por: Abu-Khader, Eman N., et al.
Publicado: (2017)

In Vivo Assessment of SMT19969 in a Hamster Model of Clostridium difficile Infection
por: Weiss, William, et al.
Publicado: (2014)

Comparison of broad-spectrum antibiotics and narrow-spectrum antibiotics in the treatment of lower extremity cellulitis
por: Almulhim, Abdulaziz Saleh, et al.
Publicado: (2018)

Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)

Etymologia: Clostridium difficile
Publicado: (2010)

Clostridium: Transmission difficile?
por: Harbarth, Stephan, et al.
Publicado: (2012)

Clostridium difficile Infection
por: Feuerstadt, Paul
Publicado: (2015)

Clostridium difficile infection
por: Geller, Stephen A., et al.
Publicado: (2014)

Clostridium difficile Infection
por: Magdesian, K. Gary
Publicado: (2003)

Antibiotic-Associated Diarrhea: Candidate Organisms other than Clostridium Difficile
por: Song, Hyun Joo, et al.
Publicado: (2008)

Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
por: Peterfreund, Gregory L., et al.
Publicado: (2012)

Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance
por: Johanesen, Priscilla A., et al.
Publicado: (2015)

Detection, Characterization and Antibiotic Susceptibility of Clostridioides (Clostridium) difficile in Meat Products
por: Muratoglu, Karlo, et al.
Publicado: (2020)

Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection
por: Vincent, Caroline, et al.
Publicado: (2013)

Immunization Using GroEL Decreases Clostridium difficile Intestinal Colonization
por: Péchiné, Séverine, et al.
Publicado: (2013)

Intestinal calcium and bile salts facilitate germination of Clostridium difficile spores
por: Kochan, Travis J., et al.
Publicado: (2017)

The Antibiotic Bacitracin Protects Human Intestinal Epithelial Cells and Stem Cell-Derived Intestinal Organoids from Clostridium difficile Toxin TcdB
por: Zhu, Ziyu, et al.
Publicado: (2019)

2422. Effectiveness of a Probiotic for Primary Prevention of Clostridium difficile Infection and Antibiotic-Associated Diarrhea among Hospitalized Patients Receiving Broad-Spectrum Antibiotics
por: Le, Khanh-Linh, et al.
Publicado: (2019)

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
por: Louie, Thomas J., et al.
Publicado: (2012)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cbrkml49i8k2p2tgi0r5jpl4vh